Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics

ClinicalTrials.gov ID: NCT00041561

Public ClinicalTrials.gov record NCT00041561. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) In Pediatrics

Study identification

NCT ID
NCT00041561
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mallinckrodt
Industry
Enrollment
55 participants

Conditions and interventions

Interventions

  • Nitrogen gas Drug
  • inhaled nitric oxide Drug

Drug

Eligibility (public fields only)

Age range
Up to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2001
Primary completion
Nov 30, 2004
Completion
Nov 30, 2004
Last update posted
Jul 25, 2016

2002 – 2004

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
Chrildren's Hospital of Orange County Orange California 92868
Stanford University Medical Center Stanford California 94305
The Children's Hospital Denver Colorado 80218
Nemours Children's Clinic Orlando Florida 32806
Children's Healthcare of Atlanta at Egleston Atlanta Georgia 30322
University of Chicago, Children's Hospital Chicago Illinois 60637
Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana 71103
The Johns Hopkins Hospital Baltimore Maryland 21287
New York Presbyterian Hospital New York New York 10021
Children's Hospital at Montefiore The Bronx New York 10467
Children's Hospital Medical Center of Akron Akron Ohio 44308
The Cleveland Clinic Foundation Cleveland Ohio 44195
Children's Hospital Columbus Ohio 43205
Oregon Health and Science University Portland Oregon 97239
The Medical University of South Carolina Charleston South Carolina 29425
University of Virginia Pediatric Critical Care Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00041561, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00041561 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →